vorasidenib
servier
['vorasidenib', 'indigo']
#asco23 simultaneous pub in for plenary lba1 by ingo mellinghoff et al: indigo: a global, randomized, double-blinded, ph 3 study of vorasidenib versus placebo in pts with residual or recurrent grade 2 glioma with an idh1/2 mutation. view abstract 
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.